ACADIA Pharmaceuticals Inc ACAD

ACADIA Pharmaceuticals Inc

Biotechnology

Healthcare

ACAD

166 M shares

NASDAQ US

traded

11 Apr 2025

listed

no

open

14.17

52 week high

20.29

high

14.61

52 week low

14.10

low

13.73

growth

-2.08 %

previous Close

14.11

P/E ratio

market cap

2.86 B

div yield

0

usd

Sep 2024

qoq

revenue

250 M

3.49 %

net incoming

32.77 M

-1.87 %

eps

0.00 %

0.00 %

eps surprise

42.86 %

net profit margin

13.09 %

0.00 %

operating incoming

31.64 M

3.97 %

net change in cash

-13.22 M

52.14 %

cash on hand

155 M

-12.41 %

cost of revenue

18.86 M

3.44 %

top top